Résultats de recherche - Portail des modèles médicaux de données (portail MDM)

Breast Cancer Swedish National Quality Registry - Report

- 07/02/2018 - 1 Formulaire, 7 Groupes Item, 43 Eléments de données, 2 Langues

Groupes Item: National Quality Register for Breast Cancer, Report, Hospital, Diagnosis, Menstruation Status, TNM Classification, Care planning, Pathology from intervention / needle core biopsy

Description of registry: The aim of the National Quality Registry for Breast Cancer is to: -in an objective and standardised manner, monitor the continuum of care from diagnosis to any recurrence and death -enable the identification of regional differences -collectively relate to current guidelines and quality targets set by specialist associations and the National Board of Health and Welfare -facilitate research and developments in breast cancer. Report Source: http://www.cancercentrum.se/samverkan/cancerdiagnoser/brost/kvalitetsregister/dokument/ Facts Owner: Kerstin Sandelin surgeon, Karolinska University Hospital, Solna kerstin.sandelin@sll.se

Oral Topotecan as Radiosensitizing Agent in Patients with Rectal Cancer; NCT00158886 - Response Assessment

- 20/08/2019 - 1 Formulaire, 4 Groupes Item, 12 Eléments de données, 1 Langue

Groupes Item: Administrative documentation, TNM clinical staging, Rectal Carcinoma, Pathological staging, Rectal Carcinoma, Sphincter, Preservation technique

Study ID: 104864/517 Clinical Study ID: 104864/517 Study Title: A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00158886 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Topotecan + Radiation therapy Trade Name: N/A Study Indication: Rectal Cancer, Carcinoma, Renal Cell

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Zytoreduktive Chirurgie / HIPEC Part 2

- 02/09/2021 - 1 Formulaire, 7 Groupes Item, 65 Eléments de données, 1 Langue

Groupes Item: Administrative Documentation, Postoperative questions, Result of Surgery, Pathological tumor staging, Tumor staging, HIPEC, Administrative Documentation

Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Woche 12

TNM Staging GSK study Prostatic neoplasms NCT00883909

- 26/11/2017 - 1 Formulaire, 2 Groupes Item, 6 Eléments de données, 1 Langue

Groupes Item: Administrative data, TNM Staging History

Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977

UKHD - Universitäts-Frauenklinik, Sektion Senologie Verlaufsblatt - Mamma Carcinom - Verlaufsangaben

- 09/03/2022 - 10 Formulaires, 3 Groupes Item, 38 Eléments de données, 1 Langue

Groupes Item: Verlaufsangaben, Präoperative Vorbereitung - Checkliste, OP und Verlauf

Routinedokumentation der Universitäts-Frauenklinik, Sektion Senologie Verlaufsblatt - Mamma Carcinom - Multimodale Brustdiagnostik. Sektionsleiter Senologie: Prof. Dr. med. Jörg Heil, MHBA

Empfehlung des postoperativen Tumorboards

1 Groupe Item 26 Eléments de données

Prätherapeutische und präoperative Konferenz(en)

5 Groupes Item 46 Eléments de données

Allgemeines: Personalien, Diagnose, Therapie und Anamnese

3 Groupes Item 43 Eléments de données

Afficher plus

Follow Up Status AML UKM

- 27/09/2021 - 1 Formulaire, 6 Groupes Item, 21 Eléments de données, 2 Langues

Groupes Item: Administrative Data, Diagnoses, Therapies/Procedures, Further details, Relapses, Further Comments

Routine documentation of University Hospital Muenster. Unit: Hematology and Internistic Oncology. Based on items of original form: FollowUp Tumornachsorge MS

Staging NSCLC (UICC and AJCC), University Hospital Cologne

- 31/03/2017 - 1 Formulaire, 2 Groupes Item, 4 Eléments de données, 1 Langue

Groupes Item: Staging of NSCLC - UICC, Staging NSCLC - AJCC

Hospital Routine Documentation Subform at the University Hospital Cologne Original Form name: CIO STADIENEINTEILUNG NSCLC.pdf

Staging PETAL Study NCT00554164 - Staging

- 18/11/2016 - 1 Formulaire, 9 Groupes Item, 60 Eléments de données, 2 Langues

Groupes Item: Patient demographics, Therapy, Staging, Lab results, Nodal involvement, Extranodal involvement, Overall result, IPI, Footer module

Positronen-Emissionstomographie-gesteuerte Therapie aggressiver Non-Hodgkin-Lymphome (PETAL-Studie) Universitätsklinikum Essen (UK Essen) EudraCT-Nummer: 2006-001641-33 NCT00554164

Tumor Documentation University Hospital Cologne

- 13/03/2017 - 1 Formulaire, 11 Groupes Item, 69 Eléments de données, 1 Langue

Groupes Item: Tumor Documentation, Status at Initial Diagnosis, Location, Recurrent Tumor, Pathology, Lymph nodes, Procedere, Operative Surgical Procedures, Therapeutic Radiology, Chemotherapy, Case Management, Palliative medicine, oncologic psychotherapy

Study Description: Hospital Routine Documentation Subform at the University Hospital Cologne. Original Form name: Tumordokumentation CIO

Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755 - Disease Staging - Baseline

- 12/07/2018 - 1 Formulaire, 9 Groupes Item, 35 Eléments de données, 1 Langue

Groupes Item: Administrative Data, Diagnostic Imaging, Head/Neck, Diagnostic Imaging; Chest, Diagnostic Imaging, Abdomen, Diagnostic Imaging, Pelvis, Diagnostic Imaging, Other, Bone Marrow Biopsy, Measurable Lymphoma Disease, Non-Measurable Disease

Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin

General Info EBMT Lymphoma - 16pp General Info EBMT Lymphoma 04 Lym.

- 31/05/2016 - 1 Formulaire, 17 Groupes Item, 224 Eléments de données, 1 Langue

Groupes Item: GENERAL INFORMATION, GENERAL INFORMATION, DISEASE, LYMPHOMA, TREATMENT GIVEN BEFORE THE 1ST TRANSPLANT, DISEASE HISTORY BEFORE HSCT, STATUS OF DISEASE AT HSCT, ADDITIONAL TREATMENT POST-HSCT, BEST DISEASE RESPONSE AT 100 DAYS POST-HSCT, FORMS TO BE FILLED IN, LYMPHOMA FOLLOW UP, GRAFT VERSUS HOST DISEASE (GvHD) SINCE LAST REPORT, OTHER COMPLICATIONS SINCE LAST REPORT, DATE(S) AND RESULTS OF ALL TESTS DONE FOR ALL DONORS, ADDITIONAL THERAPIES SINCE LAST FOLLOW UP, FIRST EVIDENCE OF RELAPSE OR PROGRESSION SINCE LAST HSCT, ADDITIONAL NOTES IF APPLICABLE

DOCUMENTED PATHOGENS (Use this table for guidance on the pathogens of interest) Bacteria: S. pneumoniae, Other gram positive (i.e.: other streptococci, staphylococci, listeria …), Haemophilus influenzae, Other gram negative (i.e.: E. coli klebsiella, proteus, serratia, pseudomonas …), Legionella sp, Mycobacteria sp, Other Fungi:Candida sp, Aspergillus sp, Pneumocystis carinii, Other Parasites: Toxoplasma gondii, Other Viruses: HSV, VZV, EBV, CMV, HHV-6, RSV, Other respiratory virus (influenza, parainfluenza,rhinovirus), Adenovirus, HBV, HCV, HIV, Papovavirus, Parvovirus, Other

German Quality Management KVWL - dataset KVWL

- 27/09/2021 - 1 Formulaire, 8 Groupes Item, 98 Eléments de données, 2 Langues

Groupes Item: Patient data, Diagnosis, Follow up, Autopsy, Tumor Expansion, Histopathology, Staging, Distant metastasis

quality management dataset German Quality Management Onkologische Qualitätssicherung der Kassenärztlichen Vereinigung Westfalen-Lippe" (OQSWL)

Mots-clés

Table des matières

Modèles de données sélectionnés